Pelage Pharmaceuticals
PrivateLast Round
Series B
Oct 15, 2025
Total Funding Raised
$150.75M
Company Overview
Pelage Pharmaceuticals is a biotechnology company that develops regenerative medicine treatments for hair loss by reactivating dormant hair follicle stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pelage Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pelage Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 15, 2025 | ||||
| Series A Extension | Aug 13, 2024 | ||||
| Series A | Feb 27, 2024 |
Pelage Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B, Series A, Series A Extension |
| Main Street Advisors | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B |
| ARCH Venture Partners | Series B |
| Visionary Ventures | Series B, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Richard Heyman joins the board of directors.
Pelage Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pelage Pharmaceuticals's valuation, stock price, and market status.